SteriLance Introduces Innovative Lancing Device in Europe
SteriLance Medical, a leader in advanced personal blood-sampling technology, is excited to announce the launch of its revolutionary Onestep™ Lancing Device and the accompanying SoftSense™ Lancets. This introduction marks SteriLance's first step into the European market, starting with select locations.
Revolutionary Lancing Technology
Onestep is described as the world’s first cap-free, four-step lancing pen, engineered specifically to enhance the user experience. This device ensures that the needle remains hidden from start to finish, utilizing the patented Total Path Control™ (TPC) vertical-drive technology. This approach allows for virtually painless blood sampling while significantly reducing preparation motion.
Unique Features of Onestep
The Onestep Lancing Device provides features that set it apart:
- Single-step needle insertion and removal: Users simply need to insert a SoftSense lancet and twist off the protective cap, eliminating the need for additional pen cap removal.
- Four-step process: The simplified action sequence—insert, twist, press, and eject—results in approximately 70% fewer actions compared to traditional lancing devices.
- Advanced needle guidance: The TPC vertical drive directs the needle in a straight line, minimizing vibration and potential tissue damage during use.
- Needle concealment: The device reassures users by keeping the needle hidden, helping to reduce anxiety related to needle usage.
A recent assessment involving 30 participants revealed that 92% reported little to no discomfort, and 87% felt a sense of security due to not seeing the needle.
Addressing a Critical Need
With around 5.1 million adults diagnosed with diabetes, Spain has one of the highest rates of diabetes prevalence in Europe. The launch of low-pain, user-friendly devices like the Onestep has the potential to support individuals in maintaining adherence to self-monitoring routines—a fundamental aspect of effective diabetes management.
Availability and Future Plans
The Onestep and SoftSense products are currently available through select physical pharmacies and partner e-commerce websites in Spain. Following the initial launch, broader distribution initiatives across various European Union markets are planned for the coming months.
Quality and Compliance
Both the Onestep and SoftSense devices have achieved CE-MDR and ISO 13485 certifications, indicating their compliance with stringent quality standards. They are specifically designed for frequent, home-based capillary blood sampling.
For further details and to explore the features of Onestep, please locate additional materials through the confirmed resources. For inquiries related to media or distribution, please reach out as needed.
Frequently Asked Questions
What is the Onestep Lancing Device?
The Onestep is a cap-free lancing device designed for painless blood sampling, using advanced technology to reduce user discomfort.
How does the Onestep differ from traditional lancing devices?
It features a single-step needle loading and a simple four-step process, making it 70% easier to use than conventional pens.
Where can I purchase the Onestep device?
It is available at select pharmacies and partner e-commerce sites in Spain, with plans for wider distribution across Europe to follow.
Who can benefit from using Onestep?
Individuals managing diabetes can benefit significantly, as the device simplifies blood sampling, possibly enhancing adherence to monitoring routines.
What certifications do Onestep and SoftSense have?
They are CE-MDR and ISO 13485 certified, complying with high-quality safety standards for medical devices.
